iShares U.S. Pharmaceuticals ETF
IHE$87.58 0.00 (0.00%)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 19, 2025 | $0.59 | 2025-12-16 | 2025-12-16 |
| September 19, 2025 | $0.31 | 2025-09-16 | 2025-09-16 |
| June 20, 2025 | $0.31 | 2025-06-16 | 2025-06-16 |
| March 21, 2025 | $0.29 | 2025-03-18 | 2025-03-18 |
| December 20, 2024 | $0.21 | 2024-12-17 | 2024-12-17 |
Dividends Summary
- Consistent Payer: iShares U.S. Pharmaceuticals ETF has rewarded shareholders with 78 dividend payments over the past 18 years.
- Total Returned Value: Investors who held IHE shares during this period received a total of $33.18 per share in dividend income.
- Latest Payout: The most recent dividend of $0.59/share was paid 35 days ago, on December 19, 2025.
- Yield & Schedule: IHE currently pays dividends quarterly with an annual yield of 1.71%.
- Dividend Growth: Since 2007, the dividend payout has grown by 287.9%, from $0.15 to $0.59.
- Growth Streak: IHE has raised its dividend for 5 consecutive payments.
Company News
Here's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors?
Pfizer became the first pharmaceutical company to agree to most-favored-nation pricing with the Trump administration, receiving a three-year tariff grace period in exchange for investing in U.S. manufacturing and potentially creating a new direct sales platform.
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
Economist Justin Wolfers warns that proposed 100% tariffs on foreign pharmaceuticals will likely be passed onto American patients and insurers, particularly for patented brand-name drugs with inelastic demand.
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Smart Beta ETF report for PJP
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?
On Jun 10, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted 11-0, unanimously recommending the approval of Eli Lilly's (LLY) Alzheimer's disease drug, donanemab.
